Edward Carr sold $2.0M of Dianthus Therapeutics (DNTH)

Executed Sep 17, disclosed Sep 18, 1 day later.

Value, as filed

$2.0M

19,300 sh across 4 lots

Executed

Sep 17

the trade date, as filed

Disclosed

Sep 18

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Edward Carr CHIEF ACCOUNTING OFFICER profile →

Edward Carr (CHIEF ACCOUNTING OFFICER) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Dianthus Therapeutics, Inc. (DNTH). The largest single filing was $3.5M of DNTH (43,182 sh across 3 lots, as filed), executed Mar 12.

The name

DNTH

Dianthus Therapeutics, Inc. DNTH · Healthcare · 18 filings in 24 months ticker →

Healthcare · Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoi…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Edward Carr in DNTH

DNTHSALE Dianthus Therapeutics, Inc. $3.5M
43,182 sh across 3 lots
Exec Mar 12
Filed Mar 13 · 5:30 PM ET